JPH10219071A - Thermosetting composition - Google Patents
Thermosetting compositionInfo
- Publication number
- JPH10219071A JPH10219071A JP9024156A JP2415697A JPH10219071A JP H10219071 A JPH10219071 A JP H10219071A JP 9024156 A JP9024156 A JP 9024156A JP 2415697 A JP2415697 A JP 2415697A JP H10219071 A JPH10219071 A JP H10219071A
- Authority
- JP
- Japan
- Prior art keywords
- liquid crystalline
- group
- monomer
- liquid crystal
- carboxylic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 23
- 229920001187 thermosetting polymer Polymers 0.000 title claims abstract description 17
- 239000000178 monomer Substances 0.000 claims abstract description 41
- 239000007788 liquid Substances 0.000 claims abstract description 23
- 150000001875 compounds Chemical class 0.000 claims abstract description 22
- 229920000106 Liquid crystal polymer Polymers 0.000 claims abstract description 16
- 125000003504 2-oxazolinyl group Chemical group O1C(=NCC1)* 0.000 claims abstract description 10
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims abstract description 6
- 239000004973 liquid crystal related substance Substances 0.000 claims description 34
- 125000002843 carboxylic acid group Chemical group 0.000 claims description 23
- 229920001577 copolymer Polymers 0.000 abstract description 14
- 239000002904 solvent Substances 0.000 abstract description 14
- 239000000463 material Substances 0.000 abstract description 5
- 125000000217 alkyl group Chemical group 0.000 abstract description 4
- 229910052736 halogen Inorganic materials 0.000 abstract description 3
- 150000002367 halogens Chemical class 0.000 abstract description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract description 3
- IMSODMZESSGVBE-UHFFFAOYSA-N 2-Oxazoline Chemical compound C1CN=CO1 IMSODMZESSGVBE-UHFFFAOYSA-N 0.000 abstract description 2
- 125000003118 aryl group Chemical group 0.000 abstract 1
- -1 methoxyethyl Chemical group 0.000 description 11
- 238000000034 method Methods 0.000 description 10
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 239000000758 substrate Substances 0.000 description 7
- 239000011248 coating agent Substances 0.000 description 6
- 238000000576 coating method Methods 0.000 description 6
- 238000001723 curing Methods 0.000 description 6
- 229920000642 polymer Polymers 0.000 description 6
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 238000003786 synthesis reaction Methods 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 4
- 230000003287 optical effect Effects 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 2
- KAGIRXVDTGQWKF-UHFFFAOYSA-N 4-[6-(2-methylprop-2-enoyloxy)hexoxy]benzoic acid Chemical compound CC(=C)C(=O)OCCCCCCOC1=CC=C(C(O)=O)C=C1 KAGIRXVDTGQWKF-UHFFFAOYSA-N 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 125000003545 alkoxy group Chemical group 0.000 description 2
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 230000001747 exhibiting effect Effects 0.000 description 2
- 229910052731 fluorine Inorganic materials 0.000 description 2
- 239000011737 fluorine Substances 0.000 description 2
- 125000003709 fluoroalkyl group Chemical group 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 150000003949 imides Chemical class 0.000 description 2
- 239000003999 initiator Substances 0.000 description 2
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- 230000000379 polymerizing effect Effects 0.000 description 2
- CYIDZMCFTVVTJO-UHFFFAOYSA-N pyromellitic acid Chemical compound OC(=O)C1=CC(C(O)=O)=C(C(O)=O)C=C1C(O)=O CYIDZMCFTVVTJO-UHFFFAOYSA-N 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 230000007704 transition Effects 0.000 description 2
- ARCGXLSVLAOJQL-UHFFFAOYSA-N trimellitic acid Chemical compound OC(=O)C1=CC=C(C(O)=O)C(C(O)=O)=C1 ARCGXLSVLAOJQL-UHFFFAOYSA-N 0.000 description 2
- DJKGDNKYTKCJKD-BPOCMEKLSA-N (1s,4r,5s,6r)-1,2,3,4,7,7-hexachlorobicyclo[2.2.1]hept-2-ene-5,6-dicarboxylic acid Chemical compound ClC1=C(Cl)[C@]2(Cl)[C@H](C(=O)O)[C@H](C(O)=O)[C@@]1(Cl)C2(Cl)Cl DJKGDNKYTKCJKD-BPOCMEKLSA-N 0.000 description 1
- MJYFYGVCLHNRKB-UHFFFAOYSA-N 1,1,2-trifluoroethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OC(F)(F)CF MJYFYGVCLHNRKB-UHFFFAOYSA-N 0.000 description 1
- 125000004955 1,4-cyclohexylene group Chemical group [H]C1([H])C([H])([H])C([H])([*:1])C([H])([H])C([H])([H])C1([H])[*:2] 0.000 description 1
- 125000001140 1,4-phenylene group Chemical group [H]C1=C([H])C([*:2])=C([H])C([H])=C1[*:1] 0.000 description 1
- PMUPSYZVABJEKC-UHFFFAOYSA-N 1-methylcyclohexane-1,2-dicarboxylic acid Chemical compound OC(=O)C1(C)CCCCC1C(O)=O PMUPSYZVABJEKC-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- QFPKSTNFHFEHJL-UHFFFAOYSA-N 2-(2-methylprop-2-enoyloxy)benzoic acid Chemical compound CC(=C)C(=O)OC1=CC=CC=C1C(O)=O QFPKSTNFHFEHJL-UHFFFAOYSA-N 0.000 description 1
- JAHNSTQSQJOJLO-UHFFFAOYSA-N 2-(3-fluorophenyl)-1h-imidazole Chemical compound FC1=CC=CC(C=2NC=CN=2)=C1 JAHNSTQSQJOJLO-UHFFFAOYSA-N 0.000 description 1
- KKKKCPPTESQGQH-UHFFFAOYSA-N 2-(4,5-dihydro-1,3-oxazol-2-yl)-4,5-dihydro-1,3-oxazole Chemical compound O1CCN=C1C1=NCCO1 KKKKCPPTESQGQH-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- KFNAHVKJFHDCSK-UHFFFAOYSA-N 2-[2-(4,5-dihydro-1,3-oxazol-2-yl)ethyl]-4,5-dihydro-1,3-oxazole Chemical compound N=1CCOC=1CCC1=NCCO1 KFNAHVKJFHDCSK-UHFFFAOYSA-N 0.000 description 1
- VOGDKZZTBPDRBD-UHFFFAOYSA-N 2-[2-(4,5-dihydro-1,3-oxazol-2-yl)phenyl]-4,5-dihydro-1,3-oxazole Chemical compound O1CCN=C1C1=CC=CC=C1C1=NCCO1 VOGDKZZTBPDRBD-UHFFFAOYSA-N 0.000 description 1
- HMOZDINWBHMBSQ-UHFFFAOYSA-N 2-[3-(4,5-dihydro-1,3-oxazol-2-yl)phenyl]-4,5-dihydro-1,3-oxazole Chemical compound O1CCN=C1C1=CC=CC(C=2OCCN=2)=C1 HMOZDINWBHMBSQ-UHFFFAOYSA-N 0.000 description 1
- GATDZUUWVARTOQ-UHFFFAOYSA-N 2-[4-(4,4-dimethyl-5h-1,3-oxazol-2-yl)phenyl]-4,4-dimethyl-5h-1,3-oxazole Chemical compound CC1(C)COC(C=2C=CC(=CC=2)C=2OCC(C)(C)N=2)=N1 GATDZUUWVARTOQ-UHFFFAOYSA-N 0.000 description 1
- PVBLPTHPHFCENZ-UHFFFAOYSA-N 2-[4-(4,5-dihydro-1,3-oxazol-2-yl)cyclohexyl]-4,5-dihydro-1,3-oxazole Chemical compound O1CCN=C1C1CCC(C=2OCCN=2)CC1 PVBLPTHPHFCENZ-UHFFFAOYSA-N 0.000 description 1
- ZDNUPMSZKVCETJ-UHFFFAOYSA-N 2-[4-(4,5-dihydro-1,3-oxazol-2-yl)phenyl]-4,5-dihydro-1,3-oxazole Chemical compound O1CCN=C1C1=CC=C(C=2OCCN=2)C=C1 ZDNUPMSZKVCETJ-UHFFFAOYSA-N 0.000 description 1
- LDXQWLJXDIZULP-UHFFFAOYSA-N 2-[6-(4,5-dihydro-1,3-oxazol-2-yl)hexyl]-4,5-dihydro-1,3-oxazole Chemical compound N=1CCOC=1CCCCCCC1=NCCO1 LDXQWLJXDIZULP-UHFFFAOYSA-N 0.000 description 1
- 125000004278 2-oxazolin-2-yl group Chemical group [H]C1([H])OC(*)=NC1([H])[H] 0.000 description 1
- ZKFOEDSYSPDTEB-UHFFFAOYSA-N 2-prop-2-enoyloxybenzoic acid Chemical compound OC(=O)C1=CC=CC=C1OC(=O)C=C ZKFOEDSYSPDTEB-UHFFFAOYSA-N 0.000 description 1
- DNCFPDURLPJGKX-UHFFFAOYSA-N 4-(2-methylprop-2-enoyloxy)benzoic acid Chemical compound CC(=C)C(=O)OC1=CC=C(C(O)=O)C=C1 DNCFPDURLPJGKX-UHFFFAOYSA-N 0.000 description 1
- UBHQPRAAGGFDID-UHFFFAOYSA-N 4-(2-prop-2-enoyloxyethoxy)benzoic acid Chemical compound OC(=O)C1=CC=C(OCCOC(=O)C=C)C=C1 UBHQPRAAGGFDID-UHFFFAOYSA-N 0.000 description 1
- UITKHKNFVCYWNG-UHFFFAOYSA-N 4-(3,4-dicarboxybenzoyl)phthalic acid Chemical compound C1=C(C(O)=O)C(C(=O)O)=CC=C1C(=O)C1=CC=C(C(O)=O)C(C(O)=O)=C1 UITKHKNFVCYWNG-UHFFFAOYSA-N 0.000 description 1
- IRQWEODKXLDORP-UHFFFAOYSA-N 4-ethenylbenzoic acid Chemical compound OC(=O)C1=CC=C(C=C)C=C1 IRQWEODKXLDORP-UHFFFAOYSA-N 0.000 description 1
- IFIUFEBEPGGBIJ-UHFFFAOYSA-N 4-methyl-4,5-dihydro-1,3-oxazole Chemical compound CC1COC=N1 IFIUFEBEPGGBIJ-UHFFFAOYSA-N 0.000 description 1
- RZZZQPNSNIVWAU-UHFFFAOYSA-N 4-prop-2-enoyloxybenzoic acid Chemical compound OC(=O)C1=CC=C(OC(=O)C=C)C=C1 RZZZQPNSNIVWAU-UHFFFAOYSA-N 0.000 description 1
- ZXJMMQWZOFQDFC-UHFFFAOYSA-N 5-methyl-2-[3-(5-methyl-4,5-dihydro-1,3-oxazol-2-yl)phenyl]-4,5-dihydro-1,3-oxazole Chemical compound O1C(C)CN=C1C1=CC=CC(C=2OC(C)CN=2)=C1 ZXJMMQWZOFQDFC-UHFFFAOYSA-N 0.000 description 1
- DEXHGMUVBNTXIN-UHFFFAOYSA-N 5-methyl-2-[4-(5-methyl-4,5-dihydro-1,3-oxazol-2-yl)phenyl]-4,5-dihydro-1,3-oxazole Chemical compound O1C(C)CN=C1C1=CC=C(C=2OC(C)CN=2)C=C1 DEXHGMUVBNTXIN-UHFFFAOYSA-N 0.000 description 1
- CIIILUMBZOGKDF-UHFFFAOYSA-N 5-methyl-4,5-dihydro-1,3-oxazole Chemical compound CC1CN=CO1 CIIILUMBZOGKDF-UHFFFAOYSA-N 0.000 description 1
- 125000004070 6 membered heterocyclic group Chemical group 0.000 description 1
- 239000004342 Benzoyl peroxide Substances 0.000 description 1
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 239000005264 High molar mass liquid crystal Substances 0.000 description 1
- 239000004977 Liquid-crystal polymers (LCPs) Substances 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
- AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 1
- KZHATIZLAHNHSV-UHFFFAOYSA-N OC(=O)C1=CC=CC=C1OCC1=CC=C(C=C)C=C1 Chemical compound OC(=O)C1=CC=CC=C1OCC1=CC=C(C=C)C=C1 KZHATIZLAHNHSV-UHFFFAOYSA-N 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 125000004183 alkoxy alkyl group Chemical group 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 235000019400 benzoyl peroxide Nutrition 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229940125782 compound 2 Drugs 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- IFDVQVHZEKPUSC-UHFFFAOYSA-N cyclohex-3-ene-1,2-dicarboxylic acid Chemical compound OC(=O)C1CCC=CC1C(O)=O IFDVQVHZEKPUSC-UHFFFAOYSA-N 0.000 description 1
- QSAWQNUELGIYBC-UHFFFAOYSA-N cyclohexane-1,2-dicarboxylic acid Chemical compound OC(=O)C1CCCCC1C(O)=O QSAWQNUELGIYBC-UHFFFAOYSA-N 0.000 description 1
- 125000005716 dioxanylene group Chemical group 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 125000005448 ethoxyethyl group Chemical group [H]C([H])([H])C([H])([H])OC([H])([H])C([H])([H])* 0.000 description 1
- 125000005745 ethoxymethyl group Chemical group [H]C([H])([H])C([H])([H])OC([H])([H])* 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 230000009477 glass transition Effects 0.000 description 1
- 125000003055 glycidyl group Chemical group C(C1CO1)* 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 150000002430 hydrocarbons Chemical group 0.000 description 1
- 229920001477 hydrophilic polymer Polymers 0.000 description 1
- 230000001678 irradiating effect Effects 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 125000005395 methacrylic acid group Chemical group 0.000 description 1
- 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 description 1
- LVHBHZANLOWSRM-UHFFFAOYSA-N methylenebutanedioic acid Natural products OC(=O)CC(=C)C(O)=O LVHBHZANLOWSRM-UHFFFAOYSA-N 0.000 description 1
- OMNKZBIFPJNNIO-UHFFFAOYSA-N n-(2-methyl-4-oxopentan-2-yl)prop-2-enamide Chemical compound CC(=O)CC(C)(C)NC(=O)C=C OMNKZBIFPJNNIO-UHFFFAOYSA-N 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- 125000004957 naphthylene group Chemical group 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000006340 pentafluoro ethyl group Chemical group FC(F)(F)C(F)(F)* 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- HJWLCRVIBGQPNF-UHFFFAOYSA-N prop-2-enylbenzene Chemical compound C=CCC1=CC=CC=C1 HJWLCRVIBGQPNF-UHFFFAOYSA-N 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 125000005551 pyridylene group Chemical group 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- UFDHBDMSHIXOKF-UHFFFAOYSA-N tetrahydrophthalic acid Natural products OC(=O)C1=C(C(O)=O)CCCC1 UFDHBDMSHIXOKF-UHFFFAOYSA-N 0.000 description 1
- 238000012719 thermal polymerization Methods 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
Landscapes
- Compositions Of Macromolecular Compounds (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Liquid Crystal Substances (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、硬化後に液晶相を
示す熱硬化性組成物に関し、詳細には、液晶相を示す重
合性単量体およびカルボン酸基を有する重合性単量体か
らなる共重合物と、分子中にオキサゾリン基を2個以上
有する化合物とからなる熱硬化性組成物に関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a thermosetting composition exhibiting a liquid crystal phase after curing, and more specifically, comprises a polymerizable monomer exhibiting a liquid crystal phase and a polymerizable monomer having a carboxylic acid group. The present invention relates to a thermosetting composition comprising a copolymer and a compound having two or more oxazoline groups in a molecule.
【0002】[0002]
【従来の技術及び発明が解決しようとする課題】近年、
液晶物質はTN型やSTN型に代表されるディスプレイ
素子等の液晶分子の可逆的運動を利用した表示媒体への
応用以外にも、その配向性と屈折率、誘電率、磁化率等
の物理的性質の異方性を利用して、位相差板、偏光板、
光偏光プリズム、各種光フィルター等の光学異方体への
応用が検討されている。2. Description of the Related Art In recent years,
Liquid crystal materials are not only applied to display media using reversible motion of liquid crystal molecules such as display elements such as TN type or STN type, but also have physical properties such as orientation, refractive index, dielectric constant, and magnetic susceptibility. Utilizing the anisotropy of properties, retardation plates, polarizing plates,
Applications to optically anisotropic bodies such as light polarizing prisms and various optical filters are being studied.
【0003】このように液晶物質を構成材料とする光学
異方体には、安定で均一な光学特性を得るために、液晶
状態における液晶分子の均一な配向状態を半永久的に固
定化して、機械的にも熱的にも安定なガラス転移温度
(以下、「Tg」ともいう)の高い、配向性に優れた重
合物とすることが必須である。As described above, in order to obtain stable and uniform optical characteristics, a uniform alignment state of liquid crystal molecules in a liquid crystal state is semi-permanently fixed to an optically anisotropic body having a liquid crystal material as a constituent material. It is essential to obtain a polymer having a high glass transition temperature (hereinafter also referred to as “Tg”), which is stable both thermally and thermally, and which has excellent orientation.
【0004】液晶状態における液晶分子の均一な配向状
態を半永久的に固定化する手段としては、例えば、重合
性官能基を有する液晶性化合物又はこのような化合物を
含有する重合性液晶組成物を、液晶状態で均一に配向さ
せた後、液晶状態を保持したまま紫外線等のエネルギー
線を照射することによって光重合させて、均一な配向状
態を半永久的に固定化する方法が既に知られている。As a means for semi-permanently fixing a uniform alignment state of liquid crystal molecules in a liquid crystal state, for example, a liquid crystal compound having a polymerizable functional group or a polymerizable liquid crystal composition containing such a compound is used. There is already known a method in which a uniform alignment state is semi-permanently fixed by uniformly irradiating an energy ray such as ultraviolet rays while maintaining the liquid crystal state after uniformly aligning the liquid crystal state.
【0005】しかしながら、この方法では光重合を行な
う為に高価な光重合開始剤が不可欠であり、また、低分
子量体などにより機械的強度が不足したり、イミド樹脂
などと積層した際に液晶性が失われるなどの問題を有し
ていた。[0005] However, in this method, an expensive photopolymerization initiator is indispensable for photopolymerization, and the mechanical strength is insufficient due to a low molecular weight substance or the like, and when a imide resin or the like is laminated, the liquid crystallinity is low. Had problems such as loss.
【0006】また、基材上に塗布した後に重合した場合
の欠点を克服する方法としては、重合性液晶組成物を光
又は熱により重合した後に、溶液として基材上に塗布し
て乾燥後、等方性液体となるまで加熱し、徐冷して液晶
状態を固定化する方法が知られている。As a method for overcoming the drawbacks of polymerization after coating on a substrate, a method of polymerizing a polymerizable liquid crystal composition by light or heat, coating the polymerizable liquid crystal composition on a substrate as a solution, drying the solution, There is known a method in which the liquid crystal is heated to an isotropic liquid and then gradually cooled to fix the liquid crystal state.
【0007】しかしながら、この方法を用いるには溶媒
への溶解性に優れた液晶性重合体であることが必要であ
る。しかも、近年はハロゲン系の有機溶剤の使用が制限
されていることからハロゲンを含まない有機溶剤への溶
解性に優れた液晶重合体が求められている。これまで具
体的に検討されてきた液晶性単量体の重合物は溶解性に
乏しいか、溶解性が高過ぎて、イミド樹脂などと積層し
た際に液晶性が失われるなどの問題を有していた。However, in order to use this method, it is necessary that the liquid crystalline polymer is excellent in solubility in a solvent. In addition, since the use of halogen-based organic solvents has been restricted in recent years, a liquid crystal polymer excellent in solubility in an organic solvent containing no halogen has been demanded. Polymers of liquid crystalline monomers that have been specifically studied so far have poor solubility or are too high in solubility, and have problems such as loss of liquid crystallinity when laminated with an imide resin or the like. I was
【0008】従って、本発明の目的は、基材上への塗布
時には溶剤への溶解性に優れ、使用時には耐溶剤性に優
れる液晶性重合体を提供することにある。Accordingly, an object of the present invention is to provide a liquid crystalline polymer which is excellent in solubility in a solvent when applied to a substrate and which is excellent in solvent resistance when used.
【0009】[0009]
【課題を解決するための手段】本発明者等は、鋭意検討
を重ねた結果、重合性の液晶性単量体およびカルボン酸
基を有する重合性単量体の共重合物と、分子中に2個以
上のオキサゾリン基を有する化合物とからなる熱硬化性
組成物が、上記目的を達成し得ることの知見をした。Means for Solving the Problems As a result of intensive studies, the present inventors have found that a copolymer of a polymerizable liquid crystal monomer and a polymerizable monomer having a carboxylic acid group, It has been found that a thermosetting composition comprising a compound having two or more oxazoline groups can achieve the above object.
【0010】本発明は、上記知見に基づきなされたもの
で、下記(A)および(B)成分からなる熱硬化性組成
物を提供するものである。 (A);カルボン酸基を有していない重合性液晶性単量
体(a)、カルボン酸基を有している重合性液晶性単量
体(b)およびカルボン酸基を有している非液晶性の重
合性単量体(c)からなる群より選ばれる少なくとも2
種の単量体を共重合して得られる、カルボン酸基を有す
る液晶性重合体。 (B);分子中に2個以上のオキサゾリン基を有する化
合物。[0010] The present invention has been made based on the above findings, and provides a thermosetting composition comprising the following components (A) and (B). (A); a polymerizable liquid crystal monomer having no carboxylic acid group (a), a polymerizable liquid crystal monomer having a carboxylic acid group (b), and a carboxylic acid group At least 2 selected from the group consisting of non-liquid crystalline polymerizable monomers (c)
A liquid crystalline polymer having a carboxylic acid group, obtained by copolymerizing various kinds of monomers. (B): a compound having two or more oxazoline groups in the molecule.
【0011】[0011]
【発明の実施の形態】以下、本発明の熱硬化性組成物に
ついて詳細に説明する。本発明に使用される(A)成分
である、カルボン酸基を有する液晶性重合体において、
カルボン酸基を有していない重合性液晶性単量体(a)
またはカルボン酸基を有している重合性液晶性単量体
(b)としては、単量体自身が液晶性を有するか、また
は、重合後に液晶性を示すエチレン性不飽和基を有する
化合物であれば特に限定されるものではなく、例えば、
下記〔化2〕(前記〔化1〕と同じ)の一般式(I)で
表される化合物(但し、(a)の場合はR2 がカルボキ
シル基以外の基、(b)の場合はR2 がカルボキシル
基)等が好ましく挙げられる。BEST MODE FOR CARRYING OUT THE INVENTION Hereinafter, the thermosetting composition of the present invention will be described in detail. In the liquid crystalline polymer having a carboxylic acid group, which is the component (A) used in the present invention,
Polymerizable liquid crystalline monomer having no carboxylic acid group (a)
Alternatively, as the polymerizable liquid crystal monomer (b) having a carboxylic acid group, the monomer itself has liquid crystallinity, or a compound having an ethylenically unsaturated group showing liquid crystallinity after polymerization. If it is not particularly limited, for example,
A compound represented by the following general formula (I) of the following [Chemical formula 2] (the same as the above [Chemical formula 1]) (However, in the case of (a), R 2 is a group other than a carboxyl group, and in the case of (b), R 2 is R 2 is a carboxyl group).
【0012】[0012]
【化2】 Embedded image
【0013】ここで、上記一般式(I)中、環A、B、
CおよびDで表される炭化水素6員環または複素6員環
で構成される基としては、1,4−フェニレン、1,4
−シクロヘキシレン、1,4−シクロヘキセニレン、ジ
オキサニレン、ピリジレン、ピリミジレン等が挙げら
れ、縮合環としてはナフチレン等が挙げられる。Here, in the general formula (I), rings A, B,
Examples of the group composed of a 6-membered hydrocarbon ring or a 6-membered heterocyclic ring represented by C and D include 1,4-phenylene, 1,4
-Cyclohexylene, 1,4-cyclohexenylene, dioxanylene, pyridylene, pyrimidylene, and the like, and examples of the condensed ring include naphthylene.
【0014】また、R2で表されるアルキル基としては、
メチル、エチル、プロピル、ブチル、イソブチル、ペン
チル、ヘキシル、ヘプチル、オクチルが挙げられ、アル
コキシ基としては、上記アルキル基に対応するアルコキ
シ基が挙げられ、アルコキシアルキル基としては、メト
キシメチル、メトキシエチル、メトキシプロピル、エト
キシメチル、エトキシエチルなどが挙げられ、フルオロ
アルキル基としては、トリフルオロメチル、ペンタフル
オロエチルなどの上記アルキル基に対応するフルオロア
ルキル基が挙げられる。Further, as the alkyl group represented by R 2 ,
Methyl, ethyl, propyl, butyl, isobutyl, pentyl, hexyl, heptyl, octyl, and the like, and the alkoxy group includes an alkoxy group corresponding to the above alkyl group.As the alkoxyalkyl group, methoxymethyl, methoxyethyl, Methoxypropyl, ethoxymethyl, ethoxyethyl and the like can be mentioned, and as the fluoroalkyl group, a fluoroalkyl group corresponding to the above alkyl group such as trifluoromethyl and pentafluoroethyl can be mentioned.
【0015】また、R2、X1およびX2で表されるハロゲン
原子としては、例えば、フッ素、塩素、臭素が挙げら
れ、得られる化合物が安定性に優れることからフッ素が
好ましい。The halogen atom represented by R 2 , X 1 and X 2 includes, for example, fluorine, chlorine and bromine, and fluorine is preferred because the resulting compound has excellent stability.
【0016】また、lは、0〜14を表し、lが14よ
り大きいと、液晶性単量体を重合して得られる液晶性重
合体の配向状態の安定性が低下する。Further, 1 represents 0 to 14. When 1 is larger than 14, the stability of the alignment state of the liquid crystalline polymer obtained by polymerizing the liquid crystalline monomer is reduced.
【0017】また、n、p、qおよびrは各々独立に0
または1を示し、2≦n+p+q+r≦4であり、これ
らの和が1では得られる重合物の液晶性が乏しくなるこ
とがあり、4より大きいと、得られる重合物が剛直にな
り配向性に乏しくなることがある。Further, n, p, q and r are each independently 0
Or 1 and 2 ≦ n + p + q + r ≦ 4. When the sum of these is 1, the liquid crystallinity of the obtained polymer may be poor. When the sum is more than 4, the obtained polymer becomes rigid and poor in orientation. May be.
【0018】従って、上記カルボン酸基を有していない
重合性液晶性単量体(a)、および上記カルボン酸基を
有する重合性液晶性単量体(b)としては、より具体的
には、前者としては、下記〔化3〕〜〔化19〕の化合
物No.1〜17等が挙げられ、後者としては、下記
〔化20〕〜〔化22〕の化合物No.18〜20が挙
げられる。ただし、本発明に係る上記重合性液晶性単量
体(a)および上記重合性液晶性単量体(b)は以下に
示す化合物により制限を受けるものではない。Therefore, the polymerizable liquid crystal monomer (a) having no carboxylic acid group and the polymerizable liquid crystal monomer (b) having a carboxylic acid group are more specifically described. And the former include compound Nos. 3 to 19 shown below. Examples of the latter include the following compound Nos. [Chemical Formula 20] to [Chemical Formula 22]. 18-20. However, the polymerizable liquid crystal monomer (a) and the polymerizable liquid crystal monomer (b) according to the present invention are not limited by the following compounds.
【0019】[0019]
【化3】 Embedded image
【0020】[0020]
【化4】 Embedded image
【0021】[0021]
【化5】 Embedded image
【0022】[0022]
【化6】 Embedded image
【0023】[0023]
【化7】 Embedded image
【0024】[0024]
【化8】 Embedded image
【0025】[0025]
【化9】 Embedded image
【0026】[0026]
【化10】 Embedded image
【0027】[0027]
【化11】 Embedded image
【0028】[0028]
【化12】 Embedded image
【0029】[0029]
【化13】 Embedded image
【0030】[0030]
【化14】 Embedded image
【0031】[0031]
【化15】 Embedded image
【0032】[0032]
【化16】 Embedded image
【0033】[0033]
【化17】 Embedded image
【0034】[0034]
【化18】 Embedded image
【0035】[0035]
【化19】 Embedded image
【0036】[0036]
【化20】 Embedded image
【0037】[0037]
【化21】 Embedded image
【0038】[0038]
【化22】 Embedded image
【0039】上記重合性液晶性単量体(a)および
(b)は、各々単独または2種以上を組み合わせて用い
ることができ、該重合性液晶性単量体(a)および/ま
たは(b)からなる構成単位部分の含有量の合計が、得
られる液晶性重合体〔(A)成分〕中好ましくは30重
量%以上、更に好ましくは50重量%以上となる量で用
いられる。該含有量の合計が30重量%未満では、得ら
れる重合体が液晶性を示さないか、示しても液晶相を示
す温度範囲が狭くなることがある。The polymerizable liquid crystal monomers (a) and (b) can be used alone or in combination of two or more, and the polymerizable liquid crystal monomers (a) and / or (b) ) Is preferably 30% by weight or more, more preferably 50% by weight or more in the obtained liquid crystalline polymer [component (A)]. If the total content is less than 30% by weight, the resulting polymer may not exhibit liquid crystallinity, or the temperature range in which the polymer exhibits a liquid crystal phase may be narrowed.
【0040】また、上記カルボン酸基を有している非液
晶性の重合性単量体(c)としては、例えば、下記〔化
23〕の一般式(II)で表される化合物等が用いられ
る。The non-liquid crystalline polymerizable monomer (c) having a carboxylic acid group is, for example, a compound represented by the following general formula (II): Can be
【0041】[0041]
【化23】 Embedded image
【0042】上記一般式(II)で表される化合物の具体
例としては、例えば、アクリル酸、メタクリル酸、アク
リロイルオキシ安息香酸、メタクリロイルオキシ安息香
酸、4−アクリロイルオキシ安息香酸、4−メタクリロ
イルオキシ安息香酸、4−(2−アクリロイルオキシエ
チルオキシ)安息香酸、4−(6−メタクリロイルオキ
シヘキシルオキシ)安息香酸、4−カルボキシスチレ
ン、4−(2−カルボキシフェノキシメチル)スチレン
などが挙げられる。Specific examples of the compound represented by the general formula (II) include, for example, acrylic acid, methacrylic acid, acryloyloxybenzoic acid, methacryloyloxybenzoic acid, 4-acryloyloxybenzoic acid, and 4-methacryloyloxybenzoic acid. Acid, 4- (2-acryloyloxyethyloxy) benzoic acid, 4- (6-methacryloyloxyhexyloxy) benzoic acid, 4-carboxystyrene, 4- (2-carboxyphenoxymethyl) styrene and the like.
【0043】また、上記(A)成分を得るに際し、得ら
れる液晶性重合体のTgなどの機械特性を調整するため
に、(a),(b)および(c)の単量体以外に必要に
応じて他の単量体を使用することができる。該他の単量
体は、上記(a)および/または(b)の単量体が前記
含有量の範囲を逸脱しない範囲で用いられることが好ま
しい。該他の単量体としては、メチル(メタ)アクリレ
ート、エチル(メタ)アクリレート、ブチル(メタ)ア
クリレート、2−エチルヘキシル(メタ)アクリレート
テトラヒドロフルフリル(メタ)アクリレート、第三ブ
チル(メタ)アクリレート、グリシジル(メタ)アクリ
レート、トリフルオロエチル(メタ)アクリレート、テ
トラフルオロプロピル(メタ)アクリレート等の(メ
タ)アクリル酸エステル、ジアセトンアクリルアミド、
スチレン、ビニルトルエン等が挙げられる。In addition, in order to adjust the mechanical properties such as Tg of the obtained liquid crystalline polymer in obtaining the above-mentioned component (A), other than the monomers (a), (b) and (c), Other monomers can be used depending on The other monomer is preferably used in a range in which the above-mentioned monomer (a) and / or (b) does not deviate from the content range. Examples of the other monomer include methyl (meth) acrylate, ethyl (meth) acrylate, butyl (meth) acrylate, 2-ethylhexyl (meth) acrylate tetrahydrofurfuryl (meth) acrylate, tertiary butyl (meth) acrylate, (Meth) acrylates such as glycidyl (meth) acrylate, trifluoroethyl (meth) acrylate, and tetrafluoropropyl (meth) acrylate; diacetone acrylamide;
Styrene, vinyltoluene and the like can be mentioned.
【0044】また、上記(A)成分を得るに際し、カル
ボン酸基を有している単量体〔(a)および(b)〕の
使用量は、得られる液晶性重合体のカルボン酸当量が5
00〜50000、特に1000〜10000となる範
囲の量が好ましい。該カルボン酸当量が500未満で
は、本発明の組成物を硬化した後にできる硬化膜が液晶
性を保持できないことがあり、50000より大きい
と、十分な熱硬化性が得られないことがある。When the component (A) is obtained, the amount of the monomer having a carboxylic acid group [(a) and (b)] is determined based on the carboxylic acid equivalent of the obtained liquid crystalline polymer. 5
An amount in the range of 00 to 50000, particularly 1000 to 10000 is preferred. If the carboxylic acid equivalent is less than 500, a cured film formed after curing the composition of the present invention may not be able to maintain liquid crystallinity, and if it is more than 50,000, sufficient thermosetting may not be obtained.
【0045】また、上記重合性液晶性単量体(a)、上
記重合性液晶性単量体(b)および上記非液晶性の重合
性単量体(c)からなる群より選ばれる少なくとも2種
の単量体を共重合する方法は特に限定されるものではな
く、例えば、ラジカル開始剤を用いた熱重合や光開始剤
を用いた光重合により得られる方法などがあげられる。Further, at least two selected from the group consisting of the polymerizable liquid crystal monomer (a), the polymerizable liquid crystal monomer (b) and the non-liquid crystal polymerizable monomer (c). The method of copolymerizing the seed monomers is not particularly limited, and examples thereof include a method obtained by thermal polymerization using a radical initiator and a method obtained by photopolymerization using a photoinitiator.
【0046】上記(A)成分である液晶性重合体は、そ
の数平均分子量が3000〜500000であることが
好ましく、5000〜300000であることが特に好
ましい。該数平均分子量が3000より小さいと、得ら
れる硬化膜の機械強度が不足して実用的でなく、500
000より大きいと有機溶剤への溶解性が低下して溶液
として基材に塗布することが困難になる。The liquid crystalline polymer as the component (A) preferably has a number average molecular weight of 3,000 to 500,000, particularly preferably 5,000 to 300,000. When the number average molecular weight is less than 3000, the resulting cured film is insufficient in mechanical strength and impractical.
If it is larger than 000, the solubility in an organic solvent is reduced, and it is difficult to apply the solution as a solution to a substrate.
【0047】本発明に使用される(B)成分である分子
中に2個以上のオキサゾリン基を有する化合物(以下、
「オキサゾリン化合物」ともいう)としては、特に限定
されるものではないが、例えば、2,2'- ビス(2- オキサ
ゾリン) 、2,2'- ビス(4- メチル-2- オキサゾリン) 、
2,2'- ビス(5- メチル-2- オキサゾリン) 、2,2'- ビス
(5,5'-ジメチルオキサゾリン) 、2,2'- ビス(4,4,4',4'
- テトラメチル-2- オキサゾリン) 、1,2-ビス(2- オキ
サゾリン-2- イル) エタン、1,4-ビス(2- オキサゾリン
-2- イル) ブタン、1,6-ビス(2- オキサゾリン-2- イ
ル) ヘキサン、1,8-ビス(2- オキサゾリン-2- イル) 、
1,4-ビス(2- オキサゾリン-2- イル) シクロヘキサン、
1,2-ビス(2- オキサゾリン-2- イル) ベンセン、1,3-ビ
ス(2- オキサゾリン-2- イル) ベンゼン、1,4-ビス(2-
オキサゾリン-2- イル) ベンゼン、1,2-ビス(5- メチル
-2- オキサゾリン-2- イル) ベンゼン、1,3-ビス(5- メ
チル-2- オキサゾリン-2- イル) ベンゼン、1,4-ビス(5
- メチル-2- オキサゾリン-2- イル) ベンゼン、1,4-ビ
ス(4,4'-ジメチル-2- オキサゾリン-2- イル) ベンゼン
等のビスオキサゾリン化合物、および、該ビスオキサゾ
リン化合物のオキサゾリン基2化学当量と多塩基性カル
ボン酸(例えばマレイン酸、琥珀酸、イタコン酸、フタ
ル酸、テトラヒドロフタル酸、ヘキサヒドロフタル酸、
メチルヘキサヒドロフタル酸、クロレンド酸、トリメリ
ット酸、ピロメリット酸、ベンゾフェノンテトラカルボ
ン酸等)のカルボキシル基1化学当量とを反応させて得
られる末端オキサゾリン基を有する化合物等を挙げるこ
とができる。Compounds having two or more oxazoline groups in the molecule (component (B)) used in the present invention (hereinafter referred to as "B")
Examples of “oxazoline compound” include, but are not particularly limited to, for example, 2,2′-bis (2-oxazoline), 2,2′-bis (4-methyl-2-oxazoline),
2,2'-bis (5-methyl-2-oxazoline), 2,2'-bis
(5,5'-dimethyloxazoline), 2,2'-bis (4,4,4 ', 4'
-Tetramethyl-2-oxazoline), 1,2-bis (2-oxazolin-2-yl) ethane, 1,4-bis (2-oxazoline)
2-yl) butane, 1,6-bis (2-oxazolin-2-yl) hexane, 1,8-bis (2-oxazolin-2-yl),
1,4-bis (2-oxazolin-2-yl) cyclohexane,
1,2-bis (2-oxazolin-2-yl) benzene, 1,3-bis (2-oxazolin-2-yl) benzene, 1,4-bis (2-
Oxazolin-2-yl) benzene, 1,2-bis (5-methyl)
2-oxazolin-2-yl) benzene, 1,3-bis (5-methyl-2-oxazolin-2-yl) benzene, 1,4-bis (5
-Methyl-2-oxazolin-2-yl) benzene, bisoxazoline compounds such as 1,4-bis (4,4'-dimethyl-2-oxazolin-2-yl) benzene, and the oxazoline group of the bisoxazoline compound 2 chemical equivalents and polybasic carboxylic acids (eg maleic acid, succinic acid, itaconic acid, phthalic acid, tetrahydrophthalic acid, hexahydrophthalic acid,
Compounds having a terminal oxazoline group obtained by reacting one chemical equivalent of a carboxyl group of methylhexahydrophthalic acid, chlorendic acid, trimellitic acid, pyromellitic acid, benzophenonetetracarboxylic acid and the like can be mentioned.
【0048】上記オキサゾリン化合物〔(B)成分〕の
前記液晶性重合体〔(A)成分〕に対する使用量の比率
(モル比)は特に限定されるものではないが、本発明に
おいては、該液晶性重合体〔(A)成分〕が有するカル
ボン酸基と、オキサゾリン化合物〔(B)成分〕が有す
るオキサゾリン基とが反応して硬化することにより、液
晶性重合体に耐溶剤性を付与するなどの改質を行うもの
であるため、カルボン酸基/オキサゾリン基が0.1〜
10、特に0.8〜1.2となるように使用されること
が好ましい。上記オキサゾリン化合物の量が大過剰(上
記範囲の下限未満)になると、得られる硬化膜は未反応
のオキサゾリン化合物を多量に含有するため耐溶剤性が
低下することがあり、また上記オキサゾリン化合物の量
が著しく不足する場合(上記範囲の上限超)は、硬化が
十分行われず、得られる硬化膜の耐溶剤性が低下した
り、未反応のカルボン酸基が多量に残存して硬化膜の電
気的特性などに悪影響を及ぼすことがある。The ratio (molar ratio) of the oxazoline compound (component (B)) to the liquid crystalline polymer (component (A)) is not particularly limited. The carboxylic acid group of the hydrophilic polymer [component (A)] and the oxazoline group of the oxazoline compound [component (B)] react and cure, thereby imparting solvent resistance to the liquid crystalline polymer. Carboxylic acid group / oxazoline group is 0.1 to
It is preferably used to be 10, especially 0.8 to 1.2. When the amount of the oxazoline compound is excessively large (less than the lower limit of the above range), the resulting cured film contains a large amount of unreacted oxazoline compound, so that the solvent resistance may be reduced. Is extremely insufficient (above the upper limit of the above range), the curing is not sufficiently performed, the solvent resistance of the obtained cured film is reduced, or an unreacted carboxylic acid group remains in a large amount, so that the electric resistance of the cured film becomes large. It may adversely affect characteristics.
【0049】本発明の熱硬化性組成物を用いて硬化膜を
得る際の硬化方法としては、通常公知の方法が挙げら
れ、例えば、前記(A)成分と前記(B)成分とを溶剤
に溶解して塗布液を得、得られた塗布液を、スピンコー
ター等によりガラス基板等の基材上に塗布した後、所望
の温度および時間で加熱して硬化する方法等が挙げられ
る。As a curing method for obtaining a cured film using the thermosetting composition of the present invention, generally known methods can be used. For example, the components (A) and (B) can be dissolved in a solvent. After dissolving to obtain a coating liquid, the obtained coating liquid is applied onto a substrate such as a glass substrate by a spin coater or the like, and then cured by heating at a desired temperature and time.
【0050】本発明の熱硬化性組成物から得られる硬化
膜は、ディスプレイ素子等の表示媒体や、位相差板、偏
光板、光偏光プリズム、各種光フィルター等の光学異方
体等、種々の液晶物質としての用途に使用される。The cured film obtained from the thermosetting composition of the present invention can be used for various media such as a display medium such as a display element and an optically anisotropic body such as a retardation plate, a polarizing plate, a light polarizing prism, and various optical filters. Used for liquid crystal materials.
【0051】[0051]
【実施例】以下、合成例および実施例により本発明の熱
硬化性組成物を更に詳細に説明する。しかしながら、本
発明はこれらの合成例および実施例により何ら制限され
るものではない。The thermosetting composition of the present invention will be described in more detail with reference to Synthesis Examples and Examples. However, the present invention is not limited by these Synthesis Examples and Examples.
【0052】先ず、実施例および比較例で使用した化合
物の具体的な合成例を示す。 〔共重合体No.1〜No.7および比較共重合体の合成〕重合
性液晶性単量体(下記〔表1〕参照)と4-(6- メタアクリロイル
オキシヘキシルオキシ) 安息香酸(以下、「MAHBA」ともい
う)とを合計で20g になるようテトラヒドロフラン200m
l に溶解し、過酸化ベンゾイルを全単量体に対して3mol
% 加え、アルゴン置換後、65℃で8 時間反応させた。反
応後、得られた反応液をメタノール2000mlに加え、生成
する白色沈澱をろ取した。得られた共重合体の収量、収
率、並びに単分散ポリスチレン換算(GPC:テトラヒ
ドロフラン)の数平均分子量(Mn)および重量平均分子
量/数平均分子量(Mw/Mn)を測定し、それらの結果を下
記〔表1〕に示す。また、得られた共重合体の相転移温
度を測定し、その結果を下記〔表2〕に示す。First, specific synthetic examples of the compounds used in Examples and Comparative Examples are shown. [Synthesis of Copolymers No. 1 to No. 7 and Comparative Copolymer] Polymerizable liquid crystalline monomer (see Table 1 below) and 4- (6-methacryloyloxyhexyloxy) benzoic acid (hereinafter , Also referred to as "MAHBA") in 200m
l and dissolve benzoyl peroxide in 3 mol
%, And the mixture was reacted at 65 ° C. for 8 hours after purging with argon. After the reaction, the resulting reaction solution was added to 2000 ml of methanol, and the resulting white precipitate was collected by filtration. The obtained copolymer was measured for yield, yield, and number average molecular weight (Mn) and weight average molecular weight / number average molecular weight (Mw / Mn) in terms of monodisperse polystyrene (GPC: tetrahydrofuran). The results are shown in Table 1 below. Further, the phase transition temperature of the obtained copolymer was measured, and the results are shown in the following [Table 2].
【0053】共重合体No.8の合成 MAHBAをメタクリル酸に替えた以外は、共重合体N
o.3と同様にして共重合体No.8を得た。得られた共重合
体の収量、収率、MnおよびMn/Mw を測定し、それらの結
果を下記〔表1〕に示す。また、得られた共重合体の相
転移温度を測定し、その結果を下記〔表2〕に示す。Synthesis of Copolymer No. 8 Copolymer No. 8 was used except that MAHBA was replaced with methacrylic acid.
Copolymer No. 8 was obtained in the same manner as in o.3. The yield, yield, Mn and Mn / Mw of the obtained copolymer were measured, and the results are shown in Table 1 below. Further, the phase transition temperature of the obtained copolymer was measured, and the results are shown in the following [Table 2].
【0054】[0054]
【表1】 [Table 1]
【0055】[0055]
【表2】 [Table 2]
【0056】実施例1−1〜1−8および比較例1−1 上記合成例により得られた共重合体3gと、該共重合体
が有するカルボン酸基と過不足なく反応する量の1,3
−フェニレンビスオキサゾリンとを、シクロヘキサノン
/メチルエチルケトン=8/2(wt/wt)(以下、
「CH/MEK」ともいう)17gに溶解して塗布液を
得た。得られた塗布液をスピンコーターでガラス基板に
塗布して150℃で1時間熱硬化した。得られた硬化膜
はいずれも光学特性である複屈折性を保持していた。得
られた硬化膜にクロロホルムまたはCH/MEKを1滴
滴下して膜の膨潤などの変化の有無を目視で観察して耐
溶剤性を評価した。変化が認められなかったものを○、
若干の膨潤を示したものを△、明白に膨潤などの変化を
示したものを×として評価した。それらの結果を下記
〔表3〕に示す。Examples 1-1 to 1-8 and Comparative Example 1-1 The amount of 1,3 g of the copolymer obtained in the above synthesis example and the amount of the carboxylic acid group which reacts with the carboxylic acid group of the copolymer without excess or shortage was 1. 3
-Phenylenebisoxazoline with cyclohexanone / methyl ethyl ketone = 8/2 (wt / wt) (hereinafter, referred to as
(CH / MEK) to obtain a coating solution. The obtained coating solution was applied to a glass substrate with a spin coater and thermally cured at 150 ° C. for 1 hour. Each of the obtained cured films retained birefringence, which is an optical property. One drop of chloroform or CH / MEK was dropped onto the obtained cured film, and the solvent resistance was evaluated by visually observing the change such as swelling of the film. If no change was observed,
Those showing slight swelling were evaluated as Δ, and those showing obvious changes such as swelling were evaluated as ×. The results are shown in Table 3 below.
【0057】比較例1−2 オキサゾリン化合物を含まない以外は、実施例1−1と
同様にして膜を得、同様の評価をした。それらの結果を
下記〔表3〕に示す。Comparative Example 1-2 A film was obtained and evaluated in the same manner as in Example 1-1 except that the oxazoline compound was not used. The results are shown in Table 3 below.
【0058】[0058]
【表3】 [Table 3]
【0059】以上の結果より、カルボン酸基を有する特
定の液晶性重合体〔前記(A)成分〕および特定のオキ
サゾリン化合物〔(B)成分〕からなる本発明の熱硬化
性組成物(実施例1−1〜1−8)は、溶剤への溶解性
に優れ、また硬化後には優れた硬化膜を提供できること
が明らかである。From the above results, the thermosetting composition of the present invention comprising the specific liquid crystalline polymer having a carboxylic acid group [the component (A)] and the specific oxazoline compound [the component (B)] (Example) It is clear that 1-1 to 1-8) have excellent solubility in a solvent and can provide an excellent cured film after curing.
【0060】[0060]
【発明の効果】本発明の熱硬化性組成物は、溶剤への溶
解性に優れ、また硬化後の硬化膜が耐溶剤性に優れるも
のである。このため、本発明の熱硬化性組成物によれ
ば、耐溶剤性に優れる高分子液晶膜を提供することがで
きる。The thermosetting composition of the present invention has excellent solubility in a solvent, and the cured film after curing has excellent solvent resistance. Therefore, according to the thermosetting composition of the present invention, a polymer liquid crystal film having excellent solvent resistance can be provided.
Claims (3)
硬化性組成物。 (A);カルボン酸基を有していない重合性液晶性単量
体(a)、カルボン酸基を有している重合性液晶性単量
体(b)およびカルボン酸基を有している非液晶性の重
合性単量体(c)からなる群より選ばれる少なくとも2
種の単量体を共重合して得られる、カルボン酸基を有す
る液晶性重合体。 (B);分子中に2個以上のオキサゾリン基を有する化
合物。1. A thermosetting composition comprising the following components (A) and (B). (A); a polymerizable liquid crystal monomer having no carboxylic acid group (a), a polymerizable liquid crystal monomer having a carboxylic acid group (b), and a carboxylic acid group At least 2 selected from the group consisting of non-liquid crystalline polymerizable monomers (c)
A liquid crystalline polymer having a carboxylic acid group, obtained by copolymerizing various kinds of monomers. (B): a compound having two or more oxazoline groups in the molecule.
(b)が、下記〔化1〕の一般式(I)で表される化合
物(但し、(a)の場合はR2 がカルボキシル基以外の
基、(b)の場合はR2 がカルボキシル基)である請求
項1記載の熱硬化性組成物。 【化1】 2. The polymerizable liquid crystalline monomer (a) or (b) is a compound represented by the following general formula (I) (wherein, in the case of (a), R 2 is The thermosetting composition according to claim 1, wherein R 2 is a group other than a carboxyl group, and in the case of (b), R 2 is a carboxyl group. Embedded image
または(b)からなる構成単位部分の含有量の合計が、
上記(A)成分である液晶性重合体中30重量%以上で
ある請求項1記載の熱硬化性組成物。3. The polymerizable liquid crystalline monomer (a) and / or
Or the sum of the contents of the structural unit portion consisting of (b) is
The thermosetting composition according to claim 1, wherein the content is 30% by weight or more in the liquid crystalline polymer as the component (A).
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP02415697A JP3995296B2 (en) | 1997-02-06 | 1997-02-06 | Thermosetting composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP02415697A JP3995296B2 (en) | 1997-02-06 | 1997-02-06 | Thermosetting composition |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH10219071A true JPH10219071A (en) | 1998-08-18 |
JP3995296B2 JP3995296B2 (en) | 2007-10-24 |
Family
ID=12130489
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP02415697A Expired - Fee Related JP3995296B2 (en) | 1997-02-06 | 1997-02-06 | Thermosetting composition |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP3995296B2 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001354732A (en) * | 2000-04-12 | 2001-12-25 | Nitto Denko Corp | Side chain type liquid crystalline polymer and method for producing the same |
JP2007304215A (en) * | 2006-05-09 | 2007-11-22 | Hayashi Telempu Co Ltd | Photo-alignment material and method for manufacturing optical element and liquid crystal alignment film |
JP2008276149A (en) * | 2007-04-27 | 2008-11-13 | Hayashi Telempu Co Ltd | Polymer film, method for fabricating molecular alignment element, and liquid crystal alignment layer |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6426632A (en) * | 1987-03-31 | 1989-01-27 | Unitika Ltd | Thermotropic liquid crystal polyester and production thereof |
JPH03215548A (en) * | 1990-01-19 | 1991-09-20 | Unitika Ltd | Molding of polymer blend |
JPH04220402A (en) * | 1990-03-07 | 1992-08-11 | Hercules Inc | Manufacture of multi-directionally oriented mesogen-containing composition |
JPH05140422A (en) * | 1991-11-18 | 1993-06-08 | Toray Ind Inc | Thermoplastic resin composition and tubular molded article |
JPH08337617A (en) * | 1995-06-12 | 1996-12-24 | Canon Inc | Polymeric liquid crystal copolymer compound, polymeric liquid crystal composition, polymeric liquid crystal element and recording device |
-
1997
- 1997-02-06 JP JP02415697A patent/JP3995296B2/en not_active Expired - Fee Related
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6426632A (en) * | 1987-03-31 | 1989-01-27 | Unitika Ltd | Thermotropic liquid crystal polyester and production thereof |
JPH03215548A (en) * | 1990-01-19 | 1991-09-20 | Unitika Ltd | Molding of polymer blend |
JPH04220402A (en) * | 1990-03-07 | 1992-08-11 | Hercules Inc | Manufacture of multi-directionally oriented mesogen-containing composition |
JPH05140422A (en) * | 1991-11-18 | 1993-06-08 | Toray Ind Inc | Thermoplastic resin composition and tubular molded article |
JPH08337617A (en) * | 1995-06-12 | 1996-12-24 | Canon Inc | Polymeric liquid crystal copolymer compound, polymeric liquid crystal composition, polymeric liquid crystal element and recording device |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001354732A (en) * | 2000-04-12 | 2001-12-25 | Nitto Denko Corp | Side chain type liquid crystalline polymer and method for producing the same |
JP2007304215A (en) * | 2006-05-09 | 2007-11-22 | Hayashi Telempu Co Ltd | Photo-alignment material and method for manufacturing optical element and liquid crystal alignment film |
JP2008276149A (en) * | 2007-04-27 | 2008-11-13 | Hayashi Telempu Co Ltd | Polymer film, method for fabricating molecular alignment element, and liquid crystal alignment layer |
Also Published As
Publication number | Publication date |
---|---|
JP3995296B2 (en) | 2007-10-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101246154B1 (en) | Polymerizable compound and composition containing the polymerizable compound | |
JP5531419B2 (en) | Compound and optical film containing the compound | |
TWI242009B (en) | (Meth)acrylic compound having an oxetanyl group and liquid crystal film produced by using same | |
JPH11130729A (en) | Trifunctional compound and high molecular liquid crystal | |
JP4087205B2 (en) | Optical film for liquid crystal display element and liquid crystal display element equipped with the film | |
JP4246536B2 (en) | Liquid crystal film and liquid crystal display element equipped with the film | |
US12012382B2 (en) | Polymerizable liquid crystal having a carbazole core | |
JP3163539B2 (en) | Liquid crystalline alignment film, method for producing liquid crystalline alignment film, and optical element using the same | |
JP4023879B2 (en) | Di (meth) acrylate compound | |
TWI555826B (en) | Polymerizable liquid crystal composition and alignment film | |
JP4522662B2 (en) | Composition for liquid crystal alignment film, liquid crystal alignment film, method for producing liquid crystal alignment film, and maleimide compound | |
WO2020260621A1 (en) | New polymerizable liquid crystal having a quinoxaline-hydrazone core | |
JP3995296B2 (en) | Thermosetting composition | |
CN114502609B (en) | Liquid crystal aligning agent, liquid crystal alignment film, liquid crystal element, polymer and compound | |
JP2004123597A (en) | Oxetanyl group-containing (meth)acrylic compound, oxetanyl group-containing side-chain type liquid crystal polymer substance derived from the compound, and polymer liquid crystal composition containing the side-chain type liquid crystal polymer substance | |
TW200932801A (en) | Process of manufacturing optical film | |
JP4678912B2 (en) | Polymer liquid crystal | |
JP4766291B2 (en) | Polymerizable liquid crystal compound, composition, and optical anisotropic body | |
JP2000154380A (en) | Spirooxazine derivative containing optically active group and optically functional medium containing the same | |
CN105393167B (en) | The manufacturing method of the board|substrate which has the liquid crystal aligning film for horizontal electric field drive type liquid crystal display elements | |
JP4010583B2 (en) | Monofunctional polymerizable compound and liquid crystalline polymer comprising the polymer | |
JP3213762B2 (en) | Manufacturing method of heat resistant optical element | |
JP2000034251A (en) | Optical compensator sheet, liquid crystal display element, discotic compound, and liquid crystal composition | |
JP4067665B2 (en) | Discotic compound and liquid crystal composition | |
JP2002265442A (en) | Maleimide derivative and method for producing photo-alignment film using the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20051130 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20051206 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20060202 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20061003 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20061128 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20070731 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20070731 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100810 Year of fee payment: 3 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100810 Year of fee payment: 3 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110810 Year of fee payment: 4 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110810 Year of fee payment: 4 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120810 Year of fee payment: 5 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130810 Year of fee payment: 6 |
|
LAPS | Cancellation because of no payment of annual fees |